# A Placebo-controlled Trial of Fractional Flow Reserve-guided Percutaneous Renal Artery Stenting Among Atherosclerosis Renal-vascular Hypertension Patients

> **NCT07111442** · NA · NOT_YET_RECRUITING · sponsor: **Peking University First Hospital** · enrollment: 200 (estimated)

## Conditions studied

- Renal Artery Stenosis Atherosclerotic
- Secondary Hypertension Renal Arterial

## Interventions

- **DIAGNOSTIC_TEST:** renal artery fractional flow reserve measurement
- **DRUG:** dopamine
- **DEVICE:** renal artery stent
- **OTHER:** sham stenting

## Key facts

- **NCT ID:** NCT07111442
- **Lead sponsor:** Peking University First Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-08-30
- **Primary completion:** 2028-08-30
- **Final completion:** 2029-08-30
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2025-08-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07111442

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07111442, "A Placebo-controlled Trial of Fractional Flow Reserve-guided Percutaneous Renal Artery Stenting Among Atherosclerosis Renal-vascular Hypertension Patients". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT07111442. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*